MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ndt/gfaf196

Медицинская библиотека · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026

QT-prolonging medications: prevalence of use and associated risks in CKD.

Liabeuf Sophie, Berdougo-Tritz Jessica, Augey Lucie, Laville Solène M, Mbarek Aïcha, Deray Gilbert, Massy Ziad A, Jadoul Michel

СтатьяОбзорПеревод в очереди

Аннотация

Chronic kidney disease (CKD) affects >10% of the global adult population and is associated with substantial cardiovascular morbidity and mortality. Sudden cardiac death (often precipitated by ventricular arrhythmias like torsades de pointes) is a leading cause of death in patients with CKD. Prolongation of the QT interval (a marker of delayed ventricular repolarization) is a significant risk factor for arrhythmia in patients with CKD, whether they are on dialysis or not. QT prolongation in CKD is multifactorial and may result from electrolyte imbalances, myocardial remodelling, autonomic dysfunction and exposure to QT-prolonging drugs. Patients on haemodialysis are particularly vulnerable to QT prolongation due to rapid intradialytic electrolyte and fluid shifts. Many drugs known to prolong the QT interval (including various selective serotonin reuptake inhibitors, antibiotics, antiemetics and antipsychotics) are frequently prescribed to patients with CKD, even though there are few data on their safety in this population. The results of several well-designed pharmaco-epidemiological analyses (all based on data from the US Renal Data System) have shown associations between QT-prolonging drugs and an elevated risk of sudden cardiac death among patients on dialysis. These findings are concerning, given the widespread use of such drugs. The objective of this narrative review is to critically evaluate the pathophysiological relevance, prevalence and cardiovascular consequences of QT-prolonging drug use in the CKD setting.

Для цитирования: Liabeuf Sophie, Berdougo-Tritz Jessica, Augey Lucie, Laville Solène M, Mbarek Aïcha, Deray Gilbert, Massy Ziad A, Jadoul Michel. QT-prolonging medications: prevalence of use and associated risks in CKD.. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2026. DOI: 10.1093/ndt/gfaf196.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.